Form D — Ernexa Therapeutics Inc.
0001641172-25-003828 · filed 2025-04-11
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $7,249,999
- Total sold
- $7,249,999
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ernexa Therapeutics Inc.
- CIK
- 748592
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1035 CAMBRIDGE STREET
CAMBRIDGE, MA 02141 - Phone
- (617) 798-6700
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Sandra Gurrola · Executive OfficerCambridge, MA Find on LinkedIn ↗
-
Sanjeev Luther · Executive OfficerCambridge, MA Find on LinkedIn ↗
-
James Bristol · DirectorCambridge, MA Find on LinkedIn ↗
-
Peter Cicala · DirectorCambridge, MA Find on LinkedIn ↗
-
Elena Ratner · DirectorCambridge, MA Find on LinkedIn ↗
-
William Wexler · DirectorCambridge, MA Find on LinkedIn ↗
View original on SEC EDGAR.